Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A H Ramirez

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Die Pharmazie|March 27, 2009
Studies of the photooxidant properties of antibacterial fluoroquinolones and their naphthalene derivativesF Vargas, T Zoltan, A H Ramirez, et al.
The Pharmacogenomics Journal|May 16, 2012
Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointesA H Ramirez, C M Shaffer, J T Delaney, et al.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotypingJ S Schildcrout, J C Denny, E Bowton, et al.
Clinical Pharmacology and Therapeutics|December 23, 2011
Predicting clopidogrel response using DNA samples linked to an electronic health recordJ T Delaney, A H Ramirez, E Bowton, et al.
Clinical Pharmacology and Therapeutics|May 17, 2012
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT projectJ M Pulley, J C Denny, J F Peterson, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Die Pharmazie|March 27, 2009
Studies of the photooxidant properties of antibacterial fluoroquinolones and their naphthalene derivativesF Vargas, T Zoltan, A H Ramirez, et al.
The Pharmacogenomics Journal|May 16, 2012
Novel rare variants in congenital cardiac arrhythmia genes are frequent in drug-induced torsades de pointesA H Ramirez, C M Shaffer, J T Delaney, et al.
Clinical Pharmacology and Therapeutics|December 27, 2012
The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metforminS L Stocker, K M Morrissey, S W Yee, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotypingJ S Schildcrout, J C Denny, E Bowton, et al.
Clinical Pharmacology and Therapeutics|December 23, 2011
Predicting clopidogrel response using DNA samples linked to an electronic health recordJ T Delaney, A H Ramirez, E Bowton, et al.
Clinical Pharmacology and Therapeutics|May 17, 2012
Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT projectJ M Pulley, J C Denny, J F Peterson, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 1